Trial document
DRKS00006234
Trial Description
Title
Aortic plaques as a source of stroke - MRI based morphological and functional analysis of the aorta.
Trial Acronym
[---]*
URL of the Trial
[---]*
Brief Summary in Lay Language
Aortic atheroma are known to be a relevant source of stroke for 20 years. However, it is unclear why they occur in specific areas of the aorta, which hemodynamic parameters have influence on their formation and progression, and if plaques of the descending aorta cause brain infarction due to diastolic blood flow reversal. This project aims to apply Magnetic Resonance Imaging (MRI) for detection and evaluation of aortic atheroma in 3D. Furthermore, functional MRI will be performed to visualize individual blood flow and evaluate the risk of embolization to the brain. All experiments will be performed on stroke patients and controls.
Brief Summary in Scientific Language
Aortic plaques are known to be a relevant source of stroke for 20 years. However, it is unclear why they occur on predilection sites, which hemodynamic parameters have influence on their formation, progression, and rupture, and if plaques of the descending aorta cause brain infarction due to diastolic blood flow reversal. This projects aims to apply the combination of functional MRI with modern image analysis methods for the evaluation of the risk of infarction due to plaques of the descending aorta on a representative cohort of stroke patients and controls. Atheroma of the aorta are detected and characterized concerning their composition by using a multi-parametric 3D/4D MRI protocol. Subsequently, the location of plaques can be correlated with local wall shear stress and elasticity of the aorta, which are acquired quantitatively by 4D flow MRI. It should be determined to what extend altered local hemodynamics are a predictor for the occurrence and rupture of vulnerable plaques. Furthermore, individual embolization pathways can be visualized and the connection between aortic atheroma and the location of cerebral infarction should be quantified using connectivity maps. Thus, the relevance of the so far neglected but numerous plaques of the descending aorta as a high-risk source of stroke can be evaluated resulting in an optimized secondary prevention in the future.
Do you plan to share individual participant data with other researchers?
[---]*
Description IPD sharing plan:
[---]*
Organizational Data
- DRKS00006234
- 2014/06/11
- [---]*
- yes
- Approved
- 227/14, Ethik-Kommission der Albert-Ludwigs-Universität Freiburg
Secondary IDs
- U1111-1157-8605
Health Condition or Problem studied
- I63 - Cerebral infarction
Interventions/Observational Groups
- Stroke patients undergo aortic MRI (3D multicontrast MRI and 4D flow MRI) for the detection and evaluation of atherosclerotic plaques and analysis of blood flow.
- Ophthalmic patients (controls) undergo aortic MRI (3D multicontrast MRI and 4D flow MRI) for the detection and evaluation of atherosclerotic plaques and analysis of blood flow.
Characteristics
- Non-interventional
- Other
- Non-randomized controlled trial
- Open (masking not used)
- [---]*
- Other
- Diagnostic
- Other
- N/A
- N/A
Primary Outcome
Quantitative analysis of the frequency of retrograde embolization from complex plaques of the descending aorta into the supra-aortic arteries in patients with undetermined and determined stroke etiology and controls.
Secondary Outcome
1. Quantification of plaque morphology using 3D multicontrast MRI. 2. In stroke patients: Testing the hypothesis that plaques occur primarily on locations with critically altered WSS and reduced PWV. 3. Correlation of aortic elasticity and flow reversal in the descending aorta.
Countries of Recruitment
- Germany
Locations of Recruitment
- University Medical Center
Recruitment
- Actual
- 2014/09/25
- 100
- Monocenter trial
- National
Inclusion Criteria
- Both, male and female
- 50 Years
- no maximum age
Additional Inclusion Criteria
1. Stroke patients: male and female, >49 years of age, acute stroke, cryptogenic stroke etiology after routine diagnostics (without TEE), visible ischemic lesion on cerebral imaging. 2. Control patients: male and female, >49 years of age, no history of cerebral or retianl ischemia.
Exclusion Criteria
Contraindications for MRI (ferromagentic prosthesis, cardiac pacemaker, implantable cardioverter defibrillator, insulin pump, large-scale tattoos with metalliferous pigment, artificial heart valves, pregnancy, chochlea implant, copper-bearing contraceptive coil, non-removable piercings, shell splinters or other metallic material), cardiac arrhythmias, bad general condition, no informed consent obtainable, strong claustrophobia, body weight over 130kg, refusal to participate in the study
Addresses
-
start of 1:1-Block address primary-sponsor
- Universitätsklinikum Freiburg Abteilung Neurologie und Neurophysiologie
- Mr. Prof. Dr. Andreas Harloff
- Breisacherstraße 64
- 79106 Freiburg
- Germany
end of 1:1-Block address primary-sponsorstart of 1:1-Block address contact primary-sponsor- ++49-0761 270-50010
- [---]*
- andreas.harloff at uniklinik-freiburg.de
- http://www.uniklinik-freiburg.de/neurologie/forschung/neurologische-arbeitsgruppen/neurovaskulaere-bildgebung.html
end of 1:1-Block address contact primary-sponsor -
start of 1:1-Block address other
- Universitätsklinikum Freiburg Abteilung Augenheilkunde
- Killianstraße 5
- 79106 Freiburg
- Germany
end of 1:1-Block address otherstart of 1:1-Block address contact other- [---]*
- [---]*
- [---]*
- [---]*
end of 1:1-Block address contact other -
start of 1:1-Block address scientific-contact
- Universitätsklinikum Freiburg Abteilung Neurologie und Neurophysiologie
- Mr. Dr. Thomas Wehrum
- Breisacherstraße 64
- 79106 Freiburg
- Germany
end of 1:1-Block address scientific-contactstart of 1:1-Block address contact scientific-contact- ++49-0761 270-50010
- [---]*
- thomas.wehrum at uniklinik-freiburg.de
- http://www.uniklinik-freiburg.de/neurologie/forschung/neurologische-arbeitsgruppen/neurovaskulaere-bildgebung.html
end of 1:1-Block address contact scientific-contact -
start of 1:1-Block address public-contact
- Universitätsklinikum FreiburgAbteilung Neurologie und Neurophysiologie
- Mr. Dr. Thomas Wehrum
- Breisacherstraße 64
- 79106 Freiburg
- Germany
end of 1:1-Block address public-contactstart of 1:1-Block address contact public-contact- ++49-0761 270-50010
- [---]*
- thomas.wehrum at uniklinik-freiburg.de
- http://www.uniklinik-freiburg.de/neurologie/forschung/neurologische-arbeitsgruppen/neurovaskulaere-bildgebung.html
end of 1:1-Block address contact public-contact
Sources of Monetary or Material Support
-
start of 1:1-Block address materialSupport
- Deutsche Forschungsgemeinschaft
- Kennedyallee 40
- 53175 Bonn
- Germany
end of 1:1-Block address materialSupportstart of 1:1-Block address contact materialSupport- [---]*
- [---]*
- [---]*
- http://www.dfg.de
end of 1:1-Block address contact materialSupport
Status
- Recruiting complete, follow-up complete
- 2015/01/31
Trial Publications, Results and other Documents
- [---]*